GTCbio主办的第4届Cell & Gene Therapy (CGT) 将于2017年9月11日至12日在美国麻州波士顿举行。本学会将齐聚研究机关及药厂代表，针对细胞治疗及基因治疗领域诞生新技术展开讨论，本届活动安排了以下会议内容。
|Dongsheng Duan, University of Missouri|
|Richard Gatti, University of California Los Angeles|
|Susan Solomon, New York Stem Cell Foundation|
|Brian Tomkowicz, Johnson & Johnson|
|Denis Rodgerson, GTCbio|
BioSpherix will be exhibiting the Xvivo System, world's first and only cytocentric barrier isolator optimized for cells. Economical and practical alternative to cleanrooms for cGMP compliant production of cells for clinical use. Get better contamination, process and quality control. Stop by the BioSpherix booth to learn more about the only total quality platform for cells!
Cancer Genetics Inc. (CGI; Nasdaq: CGIX) is a leader in enabling precision medicine in oncology from bench to bedside through the use of oncology biomarkers and molecular testing. CGI is developing a global footprint with locations in the US, India and China. The Company offers a comprehensive range of laboratory services that provide critical genomic and biomarker information. Its state-of-the-art reference labs are CLIA-certified and CAP-accredited in the US and have licensure from several states including New York State. CGI has established strong clinical research collaborations with major cancer centers such as Memorial Sloan Kettering, The Cleveland Clinic, Mayo Clinic, Keck School of Medicine at USC and the National Cancer Institute.